According to Benzinga Pro, during Q1, EchoStar (NASDAQ:SATS) earned $88.94 million, a 211.07% increase from the preceding quarter. EchoStar also posted a total of $501.53 million in sales, a 0.58% increase since Q4.
EchoStar (NASDAQ:SATS) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
EchoStar (NASDAQ:SATS) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.36 by 194.44 percent. This is a 26.19 percent increase over earnings of $0.84 per share from the same
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
EchoStar (NASDAQ:SATS) reported its Q4 earnings results on Thursday, February 24, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
EchoStar reported earnings of $-0.27 per share.
EchoStar (NASDAQ:SATS) reported quarterly sales of $498.60 million which missed the analyst consensus estimate of $507.60 million by 1.77 percent. This is a 1.91 percent increase over sales of $489.27 million the same
Pulled from Benzinga Pro data, EchoStar (NASDAQ:SATS) showed a loss in earnings since Q2, totaling $62.60 million. Sales, on the other hand, increased by 0.97% to $504.66 million during Q3.